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Cardiac metabolism of H,O, was studied by determining the concentration dependence for H,O,stimulated 
release of GSSG, an indicator for flux through the glu~thione peroxidase pathway, in perfused heart prepa- 
rations. Treatment of rats with aminot~~ole in vivo inhibited heart catalase by 83% and shifted the dose- 
response curve for GSSG release toward lower H,O, concentrations. In aminotriazole-treated rats, 50 PM 
H,O, elicited a maximal rate of GSSG release (about 5 nmol GSSG/min per g heart), whereas 200 &M H,O, 
was necessary for obtaining a similar rate of GSSG release in control rat hearts. The results show that cata- 
iase, although present at low fevels of activity in the heart compared to other organs, functions as a major 
route for detoxication of H,O, in the myocardium. 
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Catalase and glutathione peroxidase are the ma- 
jor enzymes involved in detoxication of hydrogen 
peroxide in mammalian cells. Previous studies 
have shown that the catalase activity per g heart 
tissue is very low in comparison to other organs, 
being only about 2% that of liver in the rat [1,2]. 
On the other hand, glutathione peroxidase activity 
per g tissue is similar in both heart and liver [2,3]. 
Consequently, glutathione peroxidase has been 
suggested to function as the major route for HzOz 
metabolism in the heart [3]. 
Organic hydroperoxides, such as t-B&OH, are 
metabolized by glutathione peroxidase leading to 
an elevation of intraceliular GSSG. High in- 
tracellular GSSG levels result in release of a frac- 
tion of GSSG to the extracellular environment via 
a specific transport system [3,4], GSSG release has 
thus been employed as an indirect means of flux 
Abbreviations: GSSG, oxidized glutatbione~ GSH, 
reduced glutathione; 1-BuOOH, tert-butylhydroperoxide 
through the glutathione peroxidase pathway o-71. 
In liver, compounds which enhance endogenous 
Hz02 generation, sueh as glycolate t&6], as well as 
the model redox cycling quinone menadione [?I, 
also cause GSSG release. 
To evaluate pathways for cardiac Hz02 
metabolism, we have studied the dependence of 
GSSG release from the perfused heart on infused 
HZOZ concentration in control and aminotriazole- 
treated rats. Aminotria2ole is an irreversible in- 
hibitor of catalase [!I], and was used as a way of 
selectively inactivating the catalase pathway. 
2. MATERIALS AND METHODS 
Mafe, Sprague-Hawley rats (3~-35~ g), fed 
standard chow diet, were used for all experiments. 
Rats were treated with 3-amino-1,2,4-triazole as 
described [S]. Hearts were perfused via the aorta in 
a non-recirculating mode at 6 ml/min with Krebs- 
Henseleit buffer cont~ning 5.5 mM glucose and 
2.5 mM CaCl2 equilibrated with 95% 02/Y& CC?2 
at 35-37°C. After 25 min, Hz02 was added to the 
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medium. At 60 min hearts were frozen in liquid Nz 
and stored at -70°C. Glutathione in the effluent 
perfusate and heart was measured spec- 
trophotometrically by the catalytic assay [9]. 
GSSG and total glutathione (GSH + GSSG) were 
determined from samples with and without ZV- 
ethylmaleimide treatment; GSH levels were deter- 
mined by difference [3,9]. Catalase activity of 
homogenates was assayed by following the decom- 
position of 12.5 mM Hz02 at 240 nm in a medium 
containing 50 mM KPi, 1 mM EDTA and 0.1% 
cholate, at pH 7.0 [lo]. 
3. RESULTS 
Perfused rat hearts released glutathione in the 
form of GSH at basal rates corresponding to 
0.1-0.3 nequiv. GSSG/min per g heart in different 
preparations. Exposure to Hz02 stimulated the 
release of glutathione to the perfusate (fig.1). At 
525 PM HzOz, little glutathione release above 
basal levels was detected in control rat hearts. At 
50-200 PM H202, glutathione release increased 
markedly and was maintained at nearly steady 
rates. At 1 mM H202, glutathione release rapidly 
reached a maximum then subsequently declined. 
The decline in glutathione release at 1 mM Hz02 
was accompanied by decreased and erratic heart 
rates, whereas at I 200 PM Hz02 heart rates were 
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Fig. 1. Representative experiments showing the time 
course for release of glutathione from control rat hearts 
perfused with medium containing Hz02 at 25 (A), 50 
(o), 200 (‘I) and 1000 (m) pM as described in section 2. 
Initial contact of Hz02 with the heart occurred at 
approx. 30 min. 
generally stable at 150-180 beats per min. In all 
cases, the peroxide-stimulated release of 
glutathione occurred mainly (88100%) in the 
form of GSSG rather than GSH. The maximum 
rate of GSSG release observed under our condi- 
tions was about 5 nmol/min per g heart. A similar 
rate was also found in perfusions with t-BuOOH 
(100 PM). 
Hearts from rats treated with aminotriazole 
demonstrated GSSG release at lower Hz02 concen- 
trations than control rats (fig.2). In aminotriazole- 
treated rats, 50 pM Hz02 produced a near maximal 
rate of GSSG release. Measurements in heart 
homogenates indicated that aminotriazole 
treatment had inhibited catalase by an average of 
83%. Apparent first order rate constants were: 
control, 54.8 +- 8.7 min-‘*g-l, n = 7; 
aminotriazole-treated, 9.3 f 2.5 mitt-’ *g-l, n = 6 
(p < 0.001). Glutathione peroxidase activity was 
unaffected by aminotriazole treatment. 
Total GSSG formed during exposure to peroxide 
was determined from measurements of residual in- 
tracellular GSSG and summation of GSSG re- 
leased during the perfusion period. Plots of the 
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Fig.2. Dependence of the rate of glutathione release on 
infused Hz02 concentration for hearts from control 
(stippled) and aminotriazole-treated (solid) rats. Bars 
indicate mean and lines represent SD. Data are from 2-3 
hearts at each Hz02 concentration, except for 10pM 
which represent single experiments. Data for zero Hz02 
indicate basal glutathione release before exposure to 
Hz02 (n = 1 I, control; 9, aminotriazole). 
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Fig.3. Relationship between the rate of GSSG release 
and total GSSG formed (released plus residual) during 
30 min perfusion with various concentrations of Hz02 in 
control (0) and aminotriazole-treated ( n ) rats. Data for 
control hearts perfused with various concentrations oft- 
BuOOH (A) are also included. 
rate of GSSG release as a function of total GSSG 
formed during peroxide exposure showed an iden- 
tical relationship for both aminotriazole-treated 
and control rat hearts perfused with Hz02 (fig.3). 
The same relationship was also found for perfu- 
sions with t-BuOOH. This result confirmed that 
the rate of GSSG release was a function of eleva- 
tion of intracellular GSSG [3]. At all peroxide con- 
centrations the increase of intracellular GSSG was 
accompanied by a compensating decrease in in- 
tracellular GSH. Mass balance determinations, 
measuring the sum of residual plus released GSSG 
and GSH, indicated that the total initial 
glutathione contents of the hearts were comparable 
at values of 1060 + 82 (control, n = 11) and 1130 
f 138 nequiv. GSH/g heart (aminotriazole- 
treated, n = 9). 
4. DISCUSSION 
The shift of the dose-response curve for 
H202-stimulated GSSG release after catalase in- 
hibition indicates that catalase does play a signifi- 
cant role in Hz02 metabolism in the heart. Inhibi- 
tion of catalase allows relatively more Hz02 to be 
available to glutathione peroxidase, thus increas- 
ing flux through this enzyme. Although GSSG 
release does not provide an absolute measurement 
of the glutathione peroxidase reaction because part 
of the GSSG is reduced by glutathione reductase, 
the enhanced GSSG release observed after catalase 
inhibition must be at least proportional to the nor- 
mal flux through catalase in the uninhibited state. 
Comparison of the concentration dependences of 
Hz02 and t-BuOOH for stimulating GSSG release 
likewise supports the involvement of catalase. 
Maximal rates of GSSG release are obtained with 
20-50pM t-BuOOH [3], whereas about 2OOpM 
Hz02 was necessary to achieve the same maximal 
rate in control hearts. However, with isolated 
glutathione peroxidase similar catalytic rates occur 
with either t-BuOOH or Hz02 at a given substrate 
concentration [l I]. Thus, the different concentra- 
tion dependences for GSSG release cannot be at- 
tributed to an inherent difference at the level of 
glutathione peroxidase itself. 
Studies of red blood cells [12] and liver [5], 
which contain high levels of catalase as well as 
glutathione peroxidase, have shown that both en- 
zymes contribute to Hz02 metabolism. The relative 
contribution of each pathway is dependent on the 
concentration of H202, availability of GSH and 
hydrogen donors for the peroxidase mode of 
catalase [121, and is influenced by subcellular com- 
partmentation [5]. While similar considerations 
apply to the heart, the present results demonstrate 
that catalase can provide a substantial contribution 
to cardiac detoxication of Hz02 in spite of its low 
tissue content relative to other organs. This may be 
important in regard to the actions of redox cycling 
compounds, such as the cardiac toxin adriamycin. 
The latter stimulates uperoxide and Hz02 forma- 
tion in vitro through redox cycling mechanisms in- 
volving flavoproteins [ 131, including cardiac 
mitochondrial NADH-dehydrogenase [ 11. Many 
studies have attempted to evaluate adriamycin 
redox cycling in vivo by measurements of the 
glutathione status of the heart [14,15]. However, 
the present results show that enhanced Hz02 for- 
mation from redox cycling may not necessarily 
perturb the glutathione redox state of the 
myocardium. 
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